Dihexa vs Oxytocin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Dihexa

Dihexa is a nootropic peptide derived from angiotensin IV. It has shown remarkable cognitive-enhancing properties in animal studies, being described as potentially millions of times more potent than BDNF.

Full details →

Oxytocin

Oxytocin is a natural hormone produced in the hypothalamus, often called the 'love hormone' or 'bonding hormone.' It plays key roles in social bonding, childbirth, lactation, and stress regulation.

Full details →

Side-by-Side Comparison

AspectDihexaOxytocin
MechanismActs as a hepatocyte growth factor (HGF) potentiator by binding to its receptor c-Met. Promotes synaptogenesis, neuronal survival, and cognitive enhancement through this pathway.Binds to oxytocin receptors in the brain and peripheral tissues. Promotes social bonding, reduces anxiety and stress response, and has various peripheral effects on smooth muscle contraction.
Typical DosageResearch dosing is highly variable due to extreme potency. Typical range: 10-40mg orally or sublingually. Start with lowest doses due to potency.Intranasal: 20-40 IU (international units) for social/anxiolytic effects. Clinical uses (labor induction) require IV administration under medical supervision.
AdministrationCan be taken orally, sublingually, or intranasally. Extremely potent - careful dosing is essential. Best used cyclically.Intranasal spray for behavioral effects. IV only in clinical settings. Sublingual also possible. Best used situationally rather than continuously.
Side EffectsLimited human data. Reported effects include headache, temporary brain fog during adjustment, and potential mood changes.Intranasal: headache, nasal irritation, drowsiness. May cause over-attachment or emotional sensitivity. IV (clinical): uterine hyperstimulation, water retention.
Best For

What They Have in Common

Both Dihexa and Oxytocin are commonly used for:

Key Differences

Unique to Oxytocin:

Ready to Learn More?